Skip to main content

FCER1G KO cell line available to order. KO validated by Western blot. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 93 bp deletion in exon 2 and intron 2-3.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human Fcer1g knockout THP-1 cell line (AB288699), expandable thumbnail
  • Western blot - Human Fcer1g knockout THP-1 cell line (AB288699), expandable thumbnail

Key facts

Cell type

THP-1

Species or organism

Human

Tissue

Blood

Form

Liquid

Knockout validation

Sanger Sequencing, Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 93 bp deletion in exon 2 and intron 2-3.

Alternative names

Recommended products

FCER1G KO cell line available to order. KO validated by Western blot. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 93 bp deletion in exon 2 and intron 2-3.

Key facts

Cell type

THP-1

Form

Liquid

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 93 bp deletion in exon 2 and intron 2-3.

Disease

Acute Monocytic Leukemia

Concentration
Loading...

Properties

Gene name

FCER1G

Gene editing type

Knockout

Gene editing method

CRISPR technology

Knockout validation

Sanger Sequencing, Western blot

Zygosity

Homozygous

Quality control

STR analysis

CSF1PO, VWA, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Suspension

Gender

Male

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method. Based on cell count, seed cells in an appropriate cell culture flask at a density of 4x105 cells/mL. Seeding density is given as a guide only and should be scaled to align with individual lab schedules.
4. Incubate the culture at 37°C incubator with 5% CO2. Cultures should be monitored daily.
5. THP-1 cells recover slowly from cryopreservation and therefore may not be ready for subculture for a number of days. Cells should be left as much as possible over this time and only subcultured when the cell density reaches 8x105 cells/mL.Small amounts of fresh media can be added until cell number/viability improves.

Subculture guidelines

  • All seeding densities should be based on cell counts gained by established methods.

  • Cells should be seeded at 2x105 - 3x105 cells/mL and subcultured when they have reached 8x105 cells/mL.

  • It is not recommended to allow the cell density to exceed 1x106 cells/mL.

Culture medium

RPMI + 10% FBS + 0.05 mM beta-mercaptoethanol

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions

Dry Ice

Appropriate short-term storage conditions

-196°C

Appropriate long-term storage conditions

-196°C

Notes

Recommended control: Human wild-type THP-1 cell line (Human wild-type THP-1 cell line ab281894). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

  • Upon thawing make banks as soon as possible and use each bank within 10-20 passages
  • As cell line growth can vary please attempt culture for 2 weeks from revival of initial bank before contacting the technical team.
  • We will provide viable cells that proliferate on revival.

    This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

    Product promise

    We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

    In the unlikely event of one of our products not working as expected, you are covered by our product promise.

    Full details and terms and conditions can be found here:
    Terms & Conditions.

    2 product images

    • Sanger Sequencing - Human Fcer1g knockout THP-1 cell line (ab288699), expandable thumbnail

      Sanger Sequencing - Human Fcer1g knockout THP-1 cell line (ab288699)

      93 bp deletion in exon 2 and intron 2-3.

    • Western blot - Human Fcer1g knockout THP-1 cell line (ab288699), expandable thumbnail

      Western blot - Human Fcer1g knockout THP-1 cell line (ab288699)

      False colour image of Western blot: Anti-Fcer1g antibody staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (Anti-GAPDH antibody [6C5] - Loading Control ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, the antibody was shown to bind specifically to Fcer1g. A band was observed at 10 kDa in wild-type THP-1 cell lysates with no signal observed at this size in Fcer1g knockout cell line ab288699 (knockout cell lysate ab289592). To generate this image, wild-type and Fcer1g knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

      All lanes: Anti-Fcer1g antibody at 1/1000 dilution

      Lane 1: Wild-type THP-1 cell lysate at 20 µg

      Lane 3: RAW 264.7 cell lysate at 20 µg

      Lane 4: HEK-293T cell lysate at 20 µg

      Secondary

      All lanes: Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

      Performed under reducing conditions.

      Predicted band size: 10 kDa

      Observed band size: 10 kDa

    Downloads

    Product protocols

    For this product, it's our understanding that no specific protocols are required. You can:

    Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

    For licensing inquiries, please contact partnerships@abcam.com